| Type 1 Diabetes Mellitus |
1 |
1 |
| Stem Cell Research and Therapy |
0 |
1 |
| Transplantation |
0 |
0.91 |
| Islet Cell Transplantation |
0 |
0.79 |
| Cell Transplantation |
0 |
0.73 |
| Immunocompromise |
0 |
0.46 |
| Genomic Medicine |
0 |
0.31 |
| Gene Editing |
0 |
0.29 |
| Liver |
0 |
0.2 |
| Genetics |
0 |
0.13 |
| Hypoglycemia |
0 |
0.13 |
| Immunosuppressive Therapy |
0 |
0.13 |
| Lymphocytes |
0 |
0.13 |
| Vein |
0 |
0.13 |
| Hemoglobin A1c |
0 |
0.09 |
| Blood |
0 |
0.07 |
| Brachial |
0 |
0.07 |
| Child |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| CRISPR |
0 |
0.07 |
| Food and Drug Administration (FDA) |
0 |
0.07 |
| Hemoglobin |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Laser |
0 |
0.07 |
| Massachusetts |
0 |
0.07 |
| Orbit |
0 |
0.07 |
| Surgery |
0 |
0.07 |
| Tolerance |
0 |
0.07 |
| Type 2 Diabetes Mellitus |
0 |
0.05 |